BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 19650987)

  • 1. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
    Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
    Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
    Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
    Farzana T; Shamshi TS; Irfan M; Ansari SH; Baig MI; Shakoor N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematopoietic stem cell transplantation for beta-thalassemia major].
    Zhu W; Yang M; He Y
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):265-7. PubMed ID: 11798768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome.
    Li CK; Shing MM; Chik KW; Lee V; Leung TF; Cheung AY; Yuen MP
    Bone Marrow Transplant; 2002 Jan; 29(2):101-5. PubMed ID: 11850702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord blood transplantation in children with beta-thalassemia diseases.
    Vanichsetakul P; Wacharaprechanont T; O-Charoen R; Seksarn P; Kupatawintu P
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S62-7. PubMed ID: 16083164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
    Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
    Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic peripheral blood stem cell transplantation for 3 patients with beta-thalassemia major and 1 patient with congenital idiopathic haemolytic anemia].
    Fang J; Huang S; Chen C; Wu Y; Bao R; Huang K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):452-5. PubMed ID: 11774214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA haploidentical peripheral blood stem cells transplantation for β thalassemia major].
    Wang SB; Hu DM; Li L; Yang YH; Pan XH; Liu L; Peng LH; Xie ZJ; Yin B; Liang Y; Sun XJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):844-7. PubMed ID: 22339959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for sickle cell disease.
    Walters MC; Patience M; Leisenring W; Eckman JR; Scott JP; Mentzer WC; Davies SC; Ohene-Frempong K; Bernaudin F; Matthews DC; Storb R; Sullivan KM
    N Engl J Med; 1996 Aug; 335(6):369-76. PubMed ID: 8663884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
    Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F
    Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.